Response to 'The end of the dosage of 6 Thioguanine nucleotides? Not so sureā¦'. [PDF]
Waljee AK +8 more
europepmc +1 more source
Hepatotoxicity during 6-thioguanine treatment in inflammatory bowel disease and childhood acute lymphoblastic leukaemia: A systematic review. [PDF]
Toksvang LN +6 more
europepmc +1 more source
6-Thioguanine and Its Analogs Promote Apoptosis of Castration-Resistant Prostate Cancer Cells in a BRCA2-Dependent Manner. [PDF]
Laera L +3 more
europepmc +1 more source
6-Thioguanine is a noncompetitive and slow binding inhibitor of human deubiquitinating protease USP2. [PDF]
Chuang SJ +4 more
europepmc +1 more source
6-Thioguanine inhibits rotavirus replication through suppression of Rac1 GDP/GTP cycling. [PDF]
Yin Y +11 more
europepmc +1 more source
Porcine epidemic diarrhea virus papain-like protease 2 can be noncompetitively inhibited by 6-thioguanine. [PDF]
Chu HF +6 more
europepmc +1 more source
6-Thioguanine blocks SARS-CoV-2 replication by inhibition of PLpro protease activities
Swaim CD +8 more
europepmc +1 more source
NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine. [PDF]
Valerie NC +12 more
europepmc +1 more source
Nucleoside diphosphate-linked moiety X-type motif 15 R139C genotypes impact 6-thioguanine nucleotide cut-off levels to predict thiopurine-induced leukopenia in Crohn's disease patients. [PDF]
Zhu X +9 more
europepmc +1 more source
A drug-repositioning screen for primary pancreatic ductal adenocarcinoma cells identifies 6-thioguanine as an effective therapeutic agent for TPMT-low cancer cells. [PDF]
Kim I +8 more
europepmc +1 more source

